Dramatic and Durable Responses to Romidepsin in Two Patients With the Lymphocytic Variant of Hypereosinophilic Syndrome.

Abbasi, Aleeza; Chung, Catherine; William, Basem M

Abbasi, Aleeza; Chung, Catherine; William, Basem M.

Afiliação

Abbasi A; Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH.
Chung C; Department of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH.
William BM; Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: basem.william@osumc.edu.

Clin Lymphoma Myeloma Leuk ; 20(3): e128-e130, 2020 03.

Article em En | MEDLINE | ID: mdl-32035786

Assuntos

Antibióticos Antineoplásicos/uso terapêutico; Depsipeptídeos/uso terapêutico; Síndrome Hipereosinofílica/tratamento farmacológico; Adulto; Idoso; Antibióticos Antineoplásicos/farmacologia; Depsipeptídeos/farmacologia; Feminino; Humanos

Palavras-chave

Histone deacetylase inhibitors; Hypereosinophilic syndrome; Romidepsin; Sezary syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Hipereosinofílica / Depsipeptídeos / Antibióticos Antineoplásicos Limite: Adult / Aged / Female / Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google